Nifuroxazidum
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
The medicine contains the active substance nifuroxazide. The medicine has antibacterial effects against most bacteria that cause intestinal infections.
The medicine does not affect the natural bacterial flora in the digestive tract.
The medicine works locally in the intestine. It is not absorbed from the digestive tract.
treatment of acute or chronic diarrhea in the course of bacterial infections of the digestive tract (including traveler's diarrhea, food poisoning, gastritis).
This medicine is intended for use in adults and children over 6 years of age.
If there is no improvement after 3 days or the patient feels worse, they should consult a doctor.
Before starting to take Nifuroksazyd Aflofarm, the patient should discuss it with their doctor or pharmacist.
If diarrhea persists for more than 2 or 3 days, despite taking the medicine, or if the diarrhea worsens, the patient should contact their doctor immediately. The doctor will perform tests to determine the cause of the symptoms and decide on further treatment.
In case of an allergic reaction with symptoms such as: shortness of breath, rash, itching, the patient should stop taking the medicine.
Nifuroksazyd Aflofarm should be taken with a strict diet (see section: Nifuroksazyd Aflofarm with food, drink, and alcohol).
During treatment for diarrhea, it is necessary to constantly hydrate the body with a large amount of fluids (see section: Nifuroksazyd Aflofarm with food, drink, and alcohol).
In case of severe and prolonged diarrhea, severe vomiting, or loss of appetite, intravenous hydration should be considered.
As a precaution, Nifuroksazyd Aflofarm should not be taken during pregnancy and breastfeeding.
This medicine should not be used in children under 6 years of age.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Taking Nifuroksazyd Aflofarm with the following medicines may cause a risk of a disulfiram-like reaction (severe and life-threatening intolerance reaction):
Tablets should be taken with a drink.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Pregnant women should not take this medicine unless it is prescribed by a doctor.
As a precaution, Nifuroksazyd Aflofarm should not be taken during pregnancy and breastfeeding. In women of childbearing age, Nifuroksazyd Aflofarm can be used only if they use effective contraception.
This medicine does not affect the ability to drive or operate machinery.
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist. If there are any doubts, the patient should consult their doctor or pharmacist.
Recommended dose
Adults:8 tablets (800 mg) per day in 2-4 divided doses.
Children over 6 years of age:6-8 tablets (600 mg to 800 mg) per day in 2-4 divided doses.
Tablets should be swallowed whole, without chewing or crushing. They should be taken with a sufficient amount of liquid (a glass of water).
Without consulting a doctor, the medicine should not be taken for more than 3 days. The doctor may recommend longer treatment.
In case of taking a higher dose of Nifuroksazyd Aflofarm than recommended or taking a large amount of the medicine by a child, the patient should consult their doctor or pharmacist.
The missed dose should be taken as soon as possible. If it is almost time for the next dose, the patient should not take a double dose to make up for the missed one.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
This medicine is usually well-tolerated.
Frequency not known(frequency cannot be estimated from the available data):
None.
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
This medicine should not be taken after the expiry date stated on the packaging and blister after EXP.
The expiry date refers to the last day of the month.
Batch: means batch number.
Store in a temperature below 25°C.
Medicines should not be disposed of via wastewater or household waste containers. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Coated tablets, round, biconvex, with a diameter of 8.0 mm ± 0.2 mm, yellow, smooth, and uniform surface, without spots or damage.
The package contains 24 coated tablets in a PVC/PVDC/Aluminum blister pack in a cardboard box with a leaflet.
Aflofarm Farmacja Polska Sp. z o.o.
ul. Partyzancka 133/151
95-200 Pabianice
phone: (42) 22-53-100
Aflofarm Farmacja Polska Sp. z o.o.
ul. Szkolna 31
95-054 Ksawerów
Date of last revision of the leaflet:01.08.2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.